Maorect Tablets 1 mg (Rasagiline Mesylate)
Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Ilhwa Co., Ltd.
MFDS item code 202003117 · Approved 2020.04.28
This product's status changed to Expired on 2025.04.28. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of idiopathic Parkinson's disease
This medication is used for the treatment of idiopathic Parkinson's disease. In the early stages, it is administered as monotherapy or as an adjunct to dopamine agonists to alleviate symptoms. It also assists in the treatment of motor fluctuations, particularly when there are variations in symptoms after taking medication, supporting levodopa treatment. This contributes to improving motor function and enhancing the quality of daily life for patients with Parkinson's disease.
This medicine is administered orally once daily to adults as monotherapy or adjunctive therapy. 1) Monotherapy or adjunctive therapy to a dopamine agonist: Administer 1 mg orally once daily. 2) Adjunctive therapy to levodopa: The recommended initial dose for patients taking levodopa is 0.5 mg once daily. If the dose is well tolerated but the clinical response is inadequate, it may be increased to 1 mg once daily. This medicine may be taken with or without food.
This medication should not be used in patients with allergies to the active ingredient or any other components. It should not be administered to patients who are taking other MAO inhibitors or certain natural medicines, or who have recently discontinued them within the last 2 weeks. Patients who are taking or have recently discontinued medications such as pethidine, tramadol, or dextromethorphan within the last 2 weeks should not use this medication. It should not be used in patients with moderate to severe hepatic dysfunction. This medication can cause various side effects, with common side effects including headache, dizziness, depression, fever, musculoskeletal pain, dermatitis, etc. Severe side effects such as blood disorders, angina, myocardial infarction, and cerebrovascular accidents have been reported, so if any abnormal symptoms occur, immediate consultation with a healthcare provider is necessary. Drowsiness or sudden sleep may occur while taking this medication, so caution is needed when driving or operating machinery. Moreover, this medication has serious interactions with certain drugs, so it is essential to inform your doctor or pharmacist if you are taking other medications. It can be dangerous, especially when combined with MAO inhibitors, certain analgesics, antidepressants, and sympathomimetics. Caution is required during pregnancy or breastfeeding, and the safety for children has not been established. Elderly patients do not require special dosage adjustments, but patients with impaired liver function should be cautious. In case of overdose, serious symptoms such as hypertensive crisis and serotonin syndrome may occur, requiring immediate medical attention. This medication must be kept out of reach of children and stored in a cool place between 1 and 25 degrees Celsius.
Not everyone experiences these, and they can vary from person to person.
This medication should be kept in a tightly sealed container to prevent exposure to air or moisture. A cool place with a storage temperature between 1 degree and 25 degrees Celsius is suitable. Proper storage will help maintain the effectiveness and safety of the medication.
Flat, round tablet with edges, white or nearly white
30 tablets/PTP [(10 tablets/PTP x 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Ilhwa Co., Ltd.

Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Hana Lundbeck Co., Ltd.

Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Korea Lundbeck Co., Ltd.

Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Korea Pharma Co., Ltd.

Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Myungin Pharmaceutical Co., Ltd.

Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Myungin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.